PT739212E - Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro - Google Patents

Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro

Info

Publication number
PT739212E
PT739212E PT95908628T PT95908628T PT739212E PT 739212 E PT739212 E PT 739212E PT 95908628 T PT95908628 T PT 95908628T PT 95908628 T PT95908628 T PT 95908628T PT 739212 E PT739212 E PT 739212E
Authority
PT
Portugal
Prior art keywords
interleukin
hospedeiro
enexerto
utilization
prevention
Prior art date
Application number
PT95908628T
Other languages
English (en)
Inventor
Megan Sykes
Stanley F Wolf
Original Assignee
Gen Hospital Corp
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Genetics Inst filed Critical Gen Hospital Corp
Publication of PT739212E publication Critical patent/PT739212E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT95908628T 1994-01-21 1995-01-20 Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro PT739212E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,529 US5573764A (en) 1994-01-21 1994-01-21 Use of interleukin-12 to prevent graft versus host disease

Publications (1)

Publication Number Publication Date
PT739212E true PT739212E (pt) 2002-08-30

Family

ID=22685309

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95908628T PT739212E (pt) 1994-01-21 1995-01-20 Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro

Country Status (14)

Country Link
US (2) US5573764A (pt)
EP (1) EP0739212B1 (pt)
JP (1) JP3825043B2 (pt)
AT (1) ATE215380T1 (pt)
AU (1) AU698410B2 (pt)
CA (1) CA2181568C (pt)
DE (1) DE69526206T2 (pt)
DK (1) DK0739212T3 (pt)
ES (1) ES2179096T3 (pt)
IL (1) IL112373A (pt)
PT (1) PT739212E (pt)
TW (1) TW349021B (pt)
WO (1) WO1995019786A1 (pt)
ZA (1) ZA95463B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Ｉｌ−１２用処方
WO1997016203A1 (en) * 1995-11-01 1997-05-09 Genetics Institute, Inc. Methods for administration of il-12
CA2268365A1 (en) * 1996-10-18 1998-04-30 Jeff Nordstrom Il-12 gene expression and delivery systems and uses
EP0931156A2 (en) * 1996-10-18 1999-07-28 Valentis Inc. Gene expression and delivery systems and uses
AU6150498A (en) * 1997-02-07 1998-08-26 Wistar Institute, The Methods and compositions for the inhibition of interleukin-12 production
EP0919241B1 (en) * 1997-05-16 2004-08-04 Toray Industries, Inc. Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
EP1516630A3 (en) * 1997-10-31 2006-05-03 Wyeth Use of anti-il-12 antibodies in transplantation rejection
US6080399A (en) * 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
US7115712B1 (en) * 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US7718196B2 (en) * 2001-07-02 2010-05-18 The United States Of America, As Represented By The Department Of Health And Human Services Rapamycin-resistant T cells and therapeutic uses thereof
US20040241153A1 (en) * 2001-08-31 2004-12-02 Fowler Daniel H. Methods of generating human cd4+ th1 cells
US20040258661A1 (en) * 2001-10-31 2004-12-23 Daniel Fowler Generation of use of tc1 and tc2 cells
WO2003004625A1 (en) * 2001-07-02 2003-01-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Methods of generating human cd4+ th2 cells and uses thereof
DE10248141B4 (de) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nukleinsäuren und deren Verwendung für die Gentherapie
US7939058B2 (en) 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
WO2009048560A1 (en) * 2007-10-08 2009-04-16 Intrexon Corporation Engineered dendritic cells and uses for the treatment of cancer
US20100272863A1 (en) * 2009-04-24 2010-10-28 Griebel Jonathan M Soft shaped tortillas
JP6267510B2 (ja) 2010-05-18 2018-01-24 ニューメディシンズ，インコーポレーテッド 造血を増強するためのｉｌ−１２製剤
CA2839261A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
WO2013016634A1 (en) 2011-07-27 2013-01-31 Neumedicines, Inc. Use of il-12 to generate endogenous erythropoietin
EP2766035B1 (en) * 2011-10-11 2018-03-28 Universität Zürich Prorektorat MNW Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
US11951157B2 (en) 2011-10-11 2024-04-09 Universitat Zurich Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
US9636381B2 (en) 2012-01-18 2017-05-02 Neumedicines, Inc. Methods for radiation protection by administering IL-12
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
MX2022012823A (es) * 2020-04-17 2023-01-04 Univ Leland Stanford Junior Polipéptidos modificados de il-12 e il-23 y usos de los mismos.
US20220162638A1 (en) * 2020-10-13 2022-05-26 Kriya Therapeutics, Inc. Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
IL112373A0 (en) 1995-03-30
CA2181568A1 (en) 1995-07-27
JPH09508371A (ja) 1997-08-26
US5573764A (en) 1996-11-12
AU698410B2 (en) 1998-10-29
IL112373A (en) 2006-08-01
WO1995019786A1 (en) 1995-07-27
TW349021B (en) 1999-01-01
ATE215380T1 (de) 2002-04-15
DE69526206D1 (de) 2002-05-08
EP0739212B1 (en) 2002-04-03
ES2179096T3 (es) 2003-01-16
CA2181568C (en) 2007-09-18
ZA95463B (en) 1995-09-27
JP3825043B2 (ja) 2006-09-20
EP0739212A1 (en) 1996-10-30
AU1687595A (en) 1995-08-08
DE69526206T2 (de) 2002-11-21
DK0739212T3 (da) 2002-06-03
US5756085A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
PT739212E (pt) Utilizacao de interleucina-12 para a prevencao de doenca causada pela reaccao do enxerto contra o hospedeiro
WO2000038717A3 (en) Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
FR2759581B1 (fr) Dispositif de traitement, notamment par moxa, de type acupressure
CA2282654A1 (en) Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
TR199800853T2 (xx) A�r� tedavisinde epinastin'in kullan�m�.
HK1031884A1 (en) Prostaglandin agonists and their use to treat bonedisorders.
DK0870003T4 (da) Hydrobehandlingskatalysator: sammensætning, fremstilling og anvendelse deraf
NZ335981A (en) Ketobenzamides as calpain inhibitors
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
NZ326754A (en) The use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene or salts thereof for the prophylaxis and treatment of sequelae of chronic reduced circulation in the brain in particular strokes and for neurodegenerative disorders
BG106461A (en) Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction
EP0909561A3 (en) Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder
HK1029944A1 (en) Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
EP0992243A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT
WO1999057133A3 (en) Inhibitors of nf-kb activation
IL116733A0 (en) The use of sertraline to treat cancer patients
ZA9711468B (en) New use of comt inhibitors
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
MX9601031A (es) Composicion farmaceutica para el tratamiento y prevencion del cancer de prostata.
MY118982A (en) Method of reducing tissue damage associated with ischemia
HUP9903979A3 (en) Use of nitric oxidesynthase inhibitors to treat or prevent type ii diabetes
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
NO981020D0 (no) Transdermalt terapautisk system for silatranforbindelser
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention
UA10435A (uk) Спосіб стимуляції життєдіяльhості людиhи та пристрій для його здійсhеhhя